Skip to main content

Table 3 Clinicopathological characteristics of patients who met and exceeded extended indications for endoscopic early gastric cancer treatment

From: Safety of expanded criteria for endoscopic resection of early gastric cancer in a Western cohort

 

Extended indications group (n = 58)

Exceeding extended indications group (n = 139)

p value

Age (mean ± SD)

65.7 ± 11.3

65.2 ± 12.7

0.438

Gender

 Male

34 (58.6%)

71 (51.1%)

0.352

 Female

24 (41.4%)

68 (48.9%)

Histology

 Differentiated

40 (70.2%)

52 (37.4%)

0.001

 Undifferentiated

17 (29.8%)

87 (62.6%)

No. of retrieved lymph nodes (mean ± SD)

20.7 ± 10.8

19.0 ± 7.1

0.212

Tumor invasion

 Mucosal

44 (75.5%)

34 (24.5%)

0.001

 Submucosal

14 (24.1%)

105 (75.5%)

Lymph node metastasis

 LNM+

1 (1.7%)

42 (30.2%)

0.001

 LNM-

57 (98.3%)

97 (69.8%)

Ulceration

 UL+

8 (13.8%)

70 (50.3%)

0.001

 UL-

50 (86.2%)

69 (49.7%)

Lymphovascular invasion

 LV+

0 (0%)

31 (22.3%)

0.001

 LV-

58 (100%)

108 (77.7%)

Tumor size

  < 2 cm

34 (58.6%)

41 (29.4%)

0.001

 2–3 cm

16 (27.6%)

49 (35.3%)

  > 3 cm

8 (13.8%)

49 (35.3%)

  1. All the values in bold shows significance